An Open-label Study Investigating the Efficacy and Safety of 12 – 96 Weeks of Telmisartan Treatment in Patients with Hypertension

Author: Ingino C   Farsang C   Laucevicius A   Bergovec M  

Publisher: Field House Publishing

ISSN: 0300-0605

Source: The Journal of International Medical Research, Vol.31, Iss.6, 2003-11, pp. : 561-574

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content